tradingkey.logo
tradingkey.logo
検索

Oncology Institute Inc

TOI
ウォッチリストに追加
5.280USD
-0.230-4.17%
終値 07/02, 13:00ET15分遅れの株価
522.00M時価総額
損失額直近12ヶ月PER

詳細情報 Oncology Institute Inc 企業名

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Incの企業情報

企業コードTOI
会社名Oncology Institute Inc
上場日Mar 13, 2020
最高経営責任者「CEO」Virnich (Daniel)
従業員数825
証券種類Ordinary Share
決算期末Mar 13
本社所在地18000 Studebaker Rd
都市CERRITOS
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号90703
電話番号15627353226
ウェブサイトhttps://theoncologyinstitute.com/
企業コードTOI
上場日Mar 13, 2020
最高経営責任者「CEO」Virnich (Daniel)

Oncology Institute Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
-53.54%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
-53.54%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

よくある質問

Oncology Institute Incの上位5名の株主は誰ですか?

Oncology Institute Incの上位5名の株主は以下のとおりです。Dr. Daniel Virnich, M.D.

Oncology Institute Inc(TOI)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Oncology Institute Incの株式を保有している機関は204社あり、保有株式の総市場価値は約47.47Mで、全体の47.57%を占めています。2025Q4と比較して、機関の持ち株は-10136464.00増加しています。

Oncology Institute Incの最大の収益源は何ですか?

2026Q1において、Dispensary revenue部門がOncology Institute Incにとって最大の収益を生み出しており、その金額は269.18Mで、全収益の53.54%を占めています。